Culture media is any solid or liquid preparation made precisely for the growth, storage, maintenance, and transport of microorganisms and different types of cells. The array of various media available in research allows the culturing of cell types and microorganisms. The global culture media market was valued at $3,775 million in 2016, and is estimated to reach at $6,532 million by 2023, registering a CAGR of 8.1% from 2017 to 2023.
Rise in production of biopharmaceuticals and increase in demand for cell culture media have fueled the growth of the culture media market. Moreover, increase in investments and funding for research interventions in both developed and developing countries drives the culture media market growth.
However, ethical & scientific concerns associated with culture media and dearth of skilled personnel restrict the market growth. Conversely, untapped potential of the emerging markets and increase in preference for specialty media are anticipated to provide lucrative opportunities to the key players involved in the culture media market.
The culture media market is segmented based on type, application, end user, and region. Depending on type, the market is divided into lysogeny broth, chemically defined media, classical media, serum-free media, specialty media, stem cell media, and others. By application, the culture media market is categorized into cancer research, biopharmaceuticals, regenerative medicine & tissue engineering, stem cell technologies, drug discovery, and others. According to end user, it is classified into biotechnology & pharmaceutical industry, academic institute, research laboratory, and others. As per region, the culture media market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
.
KEY BENEFITS FOR STAKEHOLDERS
This report entails a detailed quantitative analysis of the current market trends from 2016 to 2023 to identify the prevailing opportunities.
Cell culture media market size and market estimations are based on comprehensive analysis of the key developments in the industry.
In-depth analysis based on region assists to understand the regional market and the strategic business planning.
The development strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.
KEY MARKET SEGMENTS
By Type
Lysogeny Broth
Chemically Defined Media
Classical Media
Serum-free Media
Specialty Media
Stem Cell Media
Others
By Application
Cancer Research
Biopharmaceuticals
Regenerative Medicine & Tissue Engineering
Stem Cell Technologies
Drug Discovery
Others
By End User
Biotechnology & Pharmaceutical Industry
Academic Institute
Research Laboratory
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Taiwan
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
The list of key players operating in this market includes:
Thermo Fisher Scientific, Inc.
Merck & Co., Inc.
GE Healthcare
The Sartorius Group
Corning Inc.
Lonza Group
Becton, Dickinson and Company
HiMedia Laboratories
Vitro Biopharma
Bio-Rad Laboratories, Inc.
The other players included in the value chain analysis (and not included in the report) include:
Irvine Scientific
Takara Bio, Inc.
Caisson Laboratories, Inc.
Cyagen Biosciences, Inc.